VRP.L Regulatory News (VRP)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. Jan-Anders Karlsson

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Verona Pharma plc

b)

LEI

n/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.1 pence each

GB00B06GSH43

b)

Nature of the transaction

Jan-Anders Karlsson purchased 600,000 Ordinary Shares

c)

Price(s) and volume(s)

d)

Aggregated information

- Aggregated volume

- Price

600,000 Ordinary Shares at 3.249 pence per Ordinary Share

e)

Date of the transaction

9 August 2016

f)

Place of the transaction

London Stock Exchange, AIM